Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
Conclusions
In patients with ACS, higher levels of GDF-15 are associated with raised risks of all types of major non-CABG-related bleeding, spontaneous MI, and stroke as well as CV and total mortality and seem to improve risk stratification for CV-mortality and major bleeding beyond established risk factors.
Clinical Trial Registration
www.clinicaltrials.gov; NCT00391872.
Source: European Heart Journal - Category: Cardiology Authors: Hagström, E., James, S. K., Bertilsson, M., Becker, R. C., Himmelmann, A., Husted, S., Katus, H. A., Steg, P. G., Storey, R. F., Siegbahn, A., Wallentin, L., for the PLATO Investigators Tags: Acute coronary syndromes Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Clinical Trials | Clopidogrel | Coronary Artery Bypass Graft | Heart | Heart Attack | Plavix | Statistics | Stroke | Study